Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharma engaged in the development of therapies for unmet need, releases positive early-stage data for its BioLexa platform. What Happened: ...
NEW YORK, Jan. 21, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, proudly announces advancements in its intellectual property portfolio ...
Hoth Therapeutics (HOTH) responded to recent market rumors and inquiries from shareholders regarding its financial plans and ongoing clinical trials. The company affirms that it has no plans for a ...
Greysun is the lead guides editor at Game Rant, covering all the biggest AAA titles to the smaller indie gems. He's been a big Nintendo fan since the SNES days and patiently awaits a Super Mario ...
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Hoth Therapeutics HOTH is a clinical-stage ...
With May the Fourth waiting in the (Starfighter) wings, do keep your eyes peeled for all the new Star Wars releases at Disney Store — after all, to quote our favorite green Jedi Grand Master, when it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback